Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis (MaSep)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Universitätsmedizin Mannheim
Sponsor:
Information provided by (Responsible Party):
Dr. med. Ursula Hoffmann, Universitätsmedizin Mannheim
ClinicalTrials.gov Identifier:
NCT01535534
First received: February 14, 2012
Last updated: November 22, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):